A significant shift is underway in China's financial markets, as insurance companies are stepping up their engagement with the stock market. These long-term investors, often called 'patient capital,' are dramatically increasing their on-site visits to publicly traded companies, signaling a strategic pivot toward equities.
This year, insurers have conducted nearly 1,900 company visits, with a clear focus on two areas: high-dividend stocks and technology-heavy sectors. Their research is concentrated on companies listed on the STAR Market, known for semiconductors, and the ChiNext board, home to advanced manufacturing and battery makers. This isn't just a random search for returns; it's a calculated move aligning with national priorities. The pace has quickened noticeably, with the weekly rate of visits increasing from around 158 in February to nearly 180 in March, showing growing conviction.
So, what's driving this change? The primary catalyst is a series of supportive government policies. First, financial regulators have made it easier for insurers to invest in stocks. Since last year, the National Financial Regulatory Administration (NFRA) has raised the cap on how much insurers can allocate to equities and has lowered the capital risk charges for holding stocks, especially in key indices like the STAR Market. These technical but important changes make stock investments more financially efficient for insurers.
Second, this trend is reinforced by China's broader economic strategy. The government's push for 'new quality productive forces' encourages investment in high-tech industries, which is exactly where insurers are focusing their research. Additionally, new mandatory ESG (Environmental, Social, and Governance) reporting rules, effective this year, provide insurers with concrete data to make better long-term investment decisions. Themes like the 'silver economy,' targeting an aging population, also legitimize research into healthcare and related services.
Finally, the macroeconomic environment plays a crucial role. With the People's Bank of China signaling lower interest rates, the returns on safer assets like bonds have become less attractive. This pushes insurers to look for better opportunities in the stock market, prompting more in-depth research to identify promising companies. It all points to a larger story: insurers are transforming from passive information gatherers into active partners in enabling China's strategic industries.
- A-shares: The stocks of Chinese companies that trade on the mainland's Shanghai and Shenzhen stock exchanges.
- STAR Market / ChiNext: China's stock market boards focused on technology and innovative companies, often compared to the Nasdaq in the U.S.
- Patient Capital: Investment funds, typically from insurance companies or pension funds, that are invested for the long term and are not focused on short-term profits.